Under the stimulation of CCL5, glioma cells subsequently increase intracellular calcium levels, phosphorylated Ca2+/calmodulin-dependent protein kinase II (p-CaMKII), and p-Akt expression levels. The gene discussed is AKT1; the disease is central nervous system cancer.